TGFB1 and neoplasm: Breast cancer-TA-MSCs show higher levels of IL-10 and TGF-β compared to AD-MSCs, and they more effectively boost anti-inflammatory cytokine expression and Treg percentage in peripheral blood lymphocytes, indicating an increased potential to promote tumor growth [55].